FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Still Faster than EMA on Cancer Approvals

A Friends of Cancer Research study update says FDA continues to review and approve novel cancer drugs faster than the European Medicines Agency.

latest-news-card-1
Biologics

Sanofi/J&J Scrap E. Coli Vaccine Candidate

Sanofi and Johnson & Johnson stop the development of their vaccine candidate for extraintestinal pathogenic E. coli because Phase 3 data show that it ...

latest-news-card-1
Human Drugs

Court Rules for FDA in Vanda Label Case

The DC District Court rules for FDA in a Vanda Pharmaceuticals lawsuit seeking an agency order to revoke the approval of a Teva ANDA for a generic cop...

latest-news-card-1
Human Drugs

Travere Therapeutics Plans Filspari sNDA

Travere Therapeutics says it will submit an sNDA to FDA for a new indication for its Filspari to treat focal segmental glomerulosclerosis.

latest-news-card-1
Human Drugs

Pfizer Gets Expanded Approval for Adcentris

FDA approves a Pfizer supplemental BLA for Adcetris (brentuximab vedotin) in combination with lenalidomide and rituximab for treating certain adult pa...

latest-news-card-1
Human Drugs

Bioresearch Monitoring Issue at ISOThrive

FDA warns Healdsburg, CA-based ISOThrive about failing to submit an IND for two clinical trials it sponsored of an investigational drug.

latest-news-card-1
Human Drugs

CGMP Deviations at Wuhu Nuowei Chemistry

FDA warns Chinas Wuhu Chemistry about CGMP deviations in its manufacturing of active pharmaceutical ingredients.

latest-news-card-1
Medical Devices

Olympus Recalls Bronchoscope Guide Sheaths

Olympus recalls its bronchoscope single-use guide sheath kits due to potential for the radiopaque tip of the sheath component to separate and fall off...

latest-news-card-1
Human Drugs

AnaptysBio Reports Positive Data on Arthritis Drug

AnaptysBio reports positive data from a Phase 2 study of rosnilimab for treating moderate-to-severe rheumatoid arthritis.

latest-news-card-1
Medical Devices

Max Mobility Recalls Wheelchair Speed Control Dial

Max Mobility recalls its Max Mobility/Permobil Smart Drive MX2+ SpeedControl Dial for wheelchair use due to a faulty circuit board in its speed contro...